| REVIEW ARTICLE |
|
| Year : 2009 | Volume
: 8
| Issue : 2 | Page : 76-80 |
|
|
The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia
Jamilu Tukur
Department of Obstetrics and Gynaecology, Aminu Kano Teaching Hospital/ Bayero University, Kano, Nigeria
Correspondence Address:
Jamilu Tukur
Department of Obstetrics and Gynaecology, Bayero University, Kano
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1596-3519.56232
|
|
|
Background : Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant.
Method : In this article , a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate.
Results : The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported.
Conclusion : A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
